CA2604225A1 - Microparticules a surface modifiee et procedes de formation et d'utilisation associes - Google Patents
Microparticules a surface modifiee et procedes de formation et d'utilisation associes Download PDFInfo
- Publication number
- CA2604225A1 CA2604225A1 CA002604225A CA2604225A CA2604225A1 CA 2604225 A1 CA2604225 A1 CA 2604225A1 CA 002604225 A CA002604225 A CA 002604225A CA 2604225 A CA2604225 A CA 2604225A CA 2604225 A1 CA2604225 A1 CA 2604225A1
- Authority
- CA
- Canada
- Prior art keywords
- microparticle
- monolayer
- charged
- preformed
- active agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
- A61K9/5057—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Glanulating (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67537205P | 2005-04-27 | 2005-04-27 | |
US60/675,372 | 2005-04-27 | ||
US75090305P | 2005-12-16 | 2005-12-16 | |
US60/750,903 | 2005-12-16 | ||
PCT/US2006/015918 WO2006116546A1 (fr) | 2005-04-27 | 2006-04-27 | Microparticules a surface modifiee et procedes de formation et d'utilisation associes |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2604225A1 true CA2604225A1 (fr) | 2006-11-02 |
Family
ID=36928379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002604225A Abandoned CA2604225A1 (fr) | 2005-04-27 | 2006-04-27 | Microparticules a surface modifiee et procedes de formation et d'utilisation associes |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060260777A1 (fr) |
EP (1) | EP1885335A1 (fr) |
JP (1) | JP2008539259A (fr) |
CN (1) | CN101188996B (fr) |
AU (1) | AU2006241145B2 (fr) |
CA (1) | CA2604225A1 (fr) |
MX (1) | MX2007013356A (fr) |
WO (1) | WO2006116546A1 (fr) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
DE60318938T2 (de) | 2002-03-20 | 2009-01-22 | Mannkind Corp., Valencia | Inhalationsgerät |
DK1786784T3 (da) | 2004-08-20 | 2011-02-14 | Mannkind Corp | Katalyse af diketopiperazinsyntese |
JP4990142B2 (ja) | 2004-08-23 | 2012-08-01 | マンカインド コーポレイション | 薬物送達のためのジケトピペラジン塩、ジケトモルホリン塩、又はジケトジオキサン塩 |
HUE028691T2 (en) | 2005-09-14 | 2016-12-28 | Mannkind Corp | A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients |
AU2007216966C1 (en) | 2006-02-22 | 2014-03-20 | Mannkind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
DE602007008125D1 (de) | 2006-10-31 | 2010-09-09 | Surmodics Pharmaceuticals Inc | Kugelförmige polymer-teilchen |
US8697098B2 (en) | 2011-02-25 | 2014-04-15 | South Dakota State University | Polymer conjugated protein micelles |
US9233110B2 (en) | 2008-05-09 | 2016-01-12 | Omathanu P. Perumal | Protein nanocarriers for topical delivery |
ES2655921T3 (es) | 2008-06-13 | 2018-02-22 | Mannkind Corporation | Un inhalador de polvo seco y sistema para administración de fármacos |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
ES2904623T3 (es) | 2008-06-20 | 2022-04-05 | Mannkind Corp | Aparato interactivo para establecer un perfil en tiempo real de esfuerzos de inhalación |
US20100009007A1 (en) * | 2008-07-10 | 2010-01-14 | Baxter International Inc. | Non-covalent modification of microparticles and process of preparing same |
TWI532497B (zh) | 2008-08-11 | 2016-05-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US8323615B2 (en) | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing multi-phasic dispersions |
US8367427B2 (en) | 2008-08-20 | 2013-02-05 | Baxter International Inc. | Methods of processing compositions containing microparticles |
US8323685B2 (en) * | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing compositions containing microparticles |
KR102165021B1 (ko) | 2008-12-19 | 2020-10-14 | 박스알타 인코퍼레이티드 | Tfpi 억제제 및 사용 방법 |
ES2319158B1 (es) * | 2008-12-23 | 2010-01-26 | Grifols, S.A | Composicion de microparticulas biocompatibles de acido alginico para la liberacion controlada de principios activos por via intravenosa. |
MX2011006766A (es) * | 2008-12-23 | 2011-10-19 | Univ Texas | Particulas dirigidas a la inflamacion. |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
RU2487731C2 (ru) | 2009-03-04 | 2013-07-20 | Маннкайнд Корпорейшн | Усовершенствованная система доставки сухого порошкообразного лекарственного средства |
EP2405963B1 (fr) | 2009-03-11 | 2013-11-06 | MannKind Corporation | Appareil, système et procédé de mesure de résistance d'un inhalateur |
ES2347119B2 (es) * | 2009-04-22 | 2011-04-28 | Universidad De Santiago De Compostela | Nanocapsulas de poliarginina. |
WO2010144789A2 (fr) | 2009-06-12 | 2010-12-16 | Mannkind Corporation | Microparticules de dicétopipérazine avec des surfaces spécifiques définies |
WO2011056889A1 (fr) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | Appareil et méthode de simulation d'efforts d'inhalation |
RU2573409C2 (ru) * | 2009-11-04 | 2016-01-20 | Дзе Юниверсити Оф Бритиш Коламбиа | Содержащие нуклеиновые кислоты липидные частицы и относящиеся к ним способы |
JP5730983B2 (ja) | 2010-03-19 | 2015-06-10 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | Tfpi阻害剤および使用方法 |
KR20130117755A (ko) | 2010-06-21 | 2013-10-28 | 맨카인드 코포레이션 | 건조 분말 약물 운반 시스템 및 방법 |
BR112013021732B1 (pt) | 2011-02-25 | 2021-11-30 | South Dakota State University | Micela estável e utilização da micela estável |
CN105667994B (zh) | 2011-04-01 | 2018-04-06 | 曼金德公司 | 用于药物药盒的泡罩包装 |
WO2012174472A1 (fr) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | Microparticules de dicétopipérazine de capacité élevée |
WO2013063160A1 (fr) | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Procédés et compositions pour traiter la douleur |
SI2827883T1 (sl) | 2012-03-21 | 2019-08-30 | Baxalta GmbH | Inhibitorji TFPI in postopki uporabe |
EP2866792A4 (fr) | 2012-06-28 | 2016-08-17 | Ansun Biopharma Inc | Formulations de microparticules pour la délivrance au système respiratoire inférieur et central et procédés de fabrication |
EP2877204A2 (fr) * | 2012-06-28 | 2015-06-03 | Ansun Biopharma, Inc. | Formulations de microparticules pour la délivrance au système respiratoire supérieur et central et procédés de fabrication |
CN108057154B (zh) | 2012-07-12 | 2021-04-16 | 曼金德公司 | 干粉药物输送系统和方法 |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
JP6523247B2 (ja) | 2013-03-15 | 2019-05-29 | マンカインド コーポレイション | 微結晶性ジケトピペラジン粒子の製造方法および乾燥粉末組成物の製造方法 |
EP3021834A1 (fr) | 2013-07-18 | 2016-05-25 | MannKind Corporation | Compositions pharmaceutiques en poudre sèche stables à la chaleur et procédés |
EP3030294B1 (fr) | 2013-08-05 | 2020-10-07 | MannKind Corporation | Appareil d'insufflation |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
US11667906B2 (en) * | 2014-11-24 | 2023-06-06 | Corning Incorporated | Magnetic microcarriers |
BR112018009644A2 (pt) | 2015-11-12 | 2018-11-06 | Graybug Vision Inc | micropartículas agregantes sólidas modificadas na superfície, material injetável, processo para preparação de micropartículas agregantes sólidas modificadas na superfície, método para tratamento de um distúrbio ocular, e, uso de micropartículas agregantes sólidas modificadas na superfície |
JP7217022B2 (ja) | 2017-03-23 | 2023-02-02 | グレイバグ ビジョン インコーポレイテッド | 眼障害の治療のための薬物及び組成物 |
EP3621654A4 (fr) | 2017-05-10 | 2021-02-17 | Graybug Vision, Inc. | Microparticules à libération prolongée et suspensions de celles-ci destinées à une thérapie médicale |
WO2019089567A1 (fr) | 2017-10-30 | 2019-05-09 | Massachusetts Institute Of Technology | Nanoparticules couche par couche pour une thérapie par cytokines dans le traitement du cancer |
WO2020115283A1 (fr) | 2018-12-07 | 2020-06-11 | Baxalta GmbH | Anticorps bispécifiques fixant le facteur ixa et le facteur x |
WO2020114615A1 (fr) | 2018-12-07 | 2020-06-11 | Baxalta GmbH | Anticorps bispécifiques se liant au facteur ixa et au facteur x |
CN114028606B (zh) * | 2021-10-26 | 2023-06-13 | 湘雅生物医药(湖州)有限公司 | 一种壳聚糖、鱼精蛋白抗菌止血微球及其制备方法 |
CN114984746B (zh) * | 2022-08-05 | 2022-11-01 | 山东建筑大学 | 一种消杀剂及养殖废水池VOCs废气处理系统方法和装置 |
Family Cites Families (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2010115A1 (de) * | 1970-03-04 | 1971-09-16 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Mikrogranulaten |
JPS523342B2 (fr) * | 1972-01-26 | 1977-01-27 | ||
US4197893A (en) * | 1977-12-15 | 1980-04-15 | Coin Bernard J O | Reuseable puncture shield for tire casings |
US4389330A (en) * | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
US4530840A (en) * | 1982-07-29 | 1985-07-23 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
JPS60100516A (ja) * | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
US4818542A (en) * | 1983-11-14 | 1989-04-04 | The University Of Kentucky Research Foundation | Porous microspheres for drug delivery and methods for making same |
DE3678308D1 (de) * | 1985-02-07 | 1991-05-02 | Takeda Chemical Industries Ltd | Verfahren zur herstellung von mikrokapseln. |
JP2551756B2 (ja) * | 1985-05-07 | 1996-11-06 | 武田薬品工業株式会社 | ポリオキシカルボン酸エステルおよびその製造法 |
US5102872A (en) * | 1985-09-20 | 1992-04-07 | Cetus Corporation | Controlled-release formulations of interleukin-2 |
GB8601100D0 (en) * | 1986-01-17 | 1986-02-19 | Cosmas Damian Ltd | Drug delivery system |
AU612591B2 (en) * | 1986-08-11 | 1991-07-18 | Innovata Biomed Limited | Pharmaceutical formulations comprising microcapsules |
US4861627A (en) * | 1987-05-01 | 1989-08-29 | Massachusetts Institute Of Technology | Preparation of multiwall polymeric microcapsules |
US4897268A (en) * | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
US5422120A (en) * | 1988-05-30 | 1995-06-06 | Depotech Corporation | Heterovesicular liposomes |
USRE38385E1 (en) * | 1989-02-16 | 2004-01-13 | Nektar Therapeutics | Storage of materials |
WO1990013285A1 (fr) * | 1989-05-01 | 1990-11-15 | Enzytech, Inc. | Procede de production de petites particules de molecules biologiquement actives |
ATE133087T1 (de) * | 1989-05-04 | 1996-02-15 | Southern Res Inst | Einkapselungsverfahren |
JPH05502863A (ja) * | 1989-12-05 | 1993-05-20 | トランセル・コーポレイション | 生体内適用および埋め込み用コーティング組成物同種グルロン酸―アルギン酸塩およびその使用方法 |
MY107937A (en) * | 1990-02-13 | 1996-06-29 | Takeda Chemical Industries Ltd | Prolonged release microcapsules. |
GB9016885D0 (en) * | 1990-08-01 | 1990-09-12 | Scras | Sustained release pharmaceutical compositions |
US5149543A (en) * | 1990-10-05 | 1992-09-22 | Massachusetts Institute Of Technology | Ionically cross-linked polymeric microcapsules |
WO1992014449A1 (fr) * | 1991-02-20 | 1992-09-03 | Nova Pharmaceutical Corporation | Systeme d'administration microparticulaire a liberation regulee pour des proteines |
US5330768A (en) * | 1991-07-05 | 1994-07-19 | Massachusetts Institute Of Technology | Controlled drug delivery using polymer/pluronic blends |
US6063910A (en) * | 1991-11-14 | 2000-05-16 | The Trustees Of Princeton University | Preparation of protein microparticles by supercritical fluid precipitation |
US5545423A (en) * | 1991-11-25 | 1996-08-13 | Vivorx, Inc. | Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials |
US5525519A (en) * | 1992-01-07 | 1996-06-11 | Middlesex Sciences, Inc. | Method for isolating biomolecules from a biological sample with linear polymers |
US5173454A (en) * | 1992-01-09 | 1992-12-22 | Corning Incorporated | Nanocrystalline materials |
US5912015A (en) * | 1992-03-12 | 1999-06-15 | Alkermes Controlled Therapeutics, Inc. | Modulated release from biocompatible polymers |
US5286495A (en) * | 1992-05-11 | 1994-02-15 | University Of Florida | Process for microencapsulating cells |
US5417966A (en) * | 1992-06-01 | 1995-05-23 | Gc Corporation | Depilatory composition |
JP2651320B2 (ja) * | 1992-07-16 | 1997-09-10 | 田辺製薬株式会社 | 徐放性マイクロスフェア製剤の製造方法 |
JP3277342B2 (ja) * | 1992-09-02 | 2002-04-22 | 武田薬品工業株式会社 | 徐放性マイクロカプセルの製造法 |
EP0595030A3 (fr) * | 1992-10-01 | 1995-06-07 | Tanabe Seiyaku Co | Composition de microsphères à plusieurs noyaux à libération retardée et son procédé de préparation. |
ATE195652T1 (de) * | 1992-12-02 | 2000-09-15 | Alkermes Inc | Wachstumhormon enthaltende mikrosphaeren mit kontrollierter freisetzung |
US6090925A (en) * | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US5554730A (en) * | 1993-03-09 | 1996-09-10 | Middlesex Sciences, Inc. | Method and kit for making a polysaccharide-protein conjugate |
US5543158A (en) * | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
AU693821B2 (en) * | 1993-11-18 | 1998-07-09 | Sirtex Medical Limited | Controlled release preparation |
ATE212830T1 (de) * | 1993-11-19 | 2002-02-15 | Alkermes Inc | Herstellung biologisch abbaubarer, einen biologisch aktiven stoff enthaltender, mikropartikel |
US5650173A (en) * | 1993-11-19 | 1997-07-22 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of biodegradable microparticles containing a biologically active agent |
US5620883A (en) * | 1994-04-01 | 1997-04-15 | The Johns Hopkins University | Living cells microencapsulated in a polymeric membrane having two layers |
US6387399B1 (en) * | 1994-12-02 | 2002-05-14 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Microencapsulated bioactive agents and method of making |
US6265389B1 (en) * | 1995-08-31 | 2001-07-24 | Alkermes Controlled Therapeutics, Inc. | Microencapsulation and sustained release of oligonucleotides |
JP2909959B2 (ja) * | 1995-10-19 | 1999-06-23 | 三井化学株式会社 | タンパク質超薄膜固定型リアクターの製造方法及び得られたタンパク質超薄膜固定型リアクターを用いた化学反応 |
SE505146C2 (sv) * | 1995-10-19 | 1997-06-30 | Biogram Ab | Partiklar för fördröjd frisättning |
US5665428A (en) * | 1995-10-25 | 1997-09-09 | Macromed, Inc. | Preparation of peptide containing biodegradable microspheres by melt process |
US6270795B1 (en) * | 1995-11-09 | 2001-08-07 | Microbiological Research Authority | Method of making microencapsulated DNA for vaccination and gene therapy |
CA2192782C (fr) * | 1995-12-15 | 2008-10-14 | Nobuyuki Takechi | Production de microsphere |
JP2966795B2 (ja) * | 1996-09-30 | 1999-10-25 | 科学技術振興事業団 | 機能性薄膜とその製造方法 |
DK0951280T3 (da) * | 1996-10-03 | 2004-05-17 | Hermes Biosciences Inc | Hydrofile mikropartikler og fremgangsmåder til fremstilling heraf |
US6083484A (en) * | 1996-10-17 | 2000-07-04 | Molecular Biosystems, Inc. | Microparticles stabilized by polynuclear chromium complexes and their use as ultrasound contrast agents |
US6395302B1 (en) * | 1996-11-19 | 2002-05-28 | Octoplus B.V. | Method for the preparation of microspheres which contain colloidal systems |
US5945126A (en) * | 1997-02-13 | 1999-08-31 | Oakwood Laboratories L.L.C. | Continuous microsphere process |
SE512663C2 (sv) * | 1997-10-23 | 2000-04-17 | Biogram Ab | Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer |
US6541606B2 (en) * | 1997-12-31 | 2003-04-01 | Altus Biologics Inc. | Stabilized protein crystals formulations containing them and methods of making them |
US6395253B2 (en) * | 1998-04-23 | 2002-05-28 | The Regents Of The University Of Michigan | Microspheres containing condensed polyanionic bioactive agents and methods for their production |
DE59914547D1 (de) * | 1998-07-15 | 2007-12-20 | Max Planck Gesellschaft | Polyelektrolythüllen auf biologischen templaten |
US6270802B1 (en) * | 1998-10-28 | 2001-08-07 | Oakwood Laboratories L.L.C. | Method and apparatus for formulating microspheres and microcapsules |
DE19852928C1 (de) * | 1998-11-17 | 2000-08-03 | Steffen Panzner | Strukturen in Form von Hohlkugeln |
US6194006B1 (en) * | 1998-12-30 | 2001-02-27 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of microparticles having a selected release profile |
ATE226267T1 (de) * | 1999-06-10 | 2002-11-15 | Max Planck Gesellschaft | Einkapselung von kristallen mit mehrschichtigem überzug |
US6458387B1 (en) * | 1999-10-18 | 2002-10-01 | Epic Therapeutics, Inc. | Sustained release microspheres |
DE10001172A1 (de) * | 2000-01-13 | 2001-07-26 | Max Planck Gesellschaft | Templatieren von Feststoffpartikeln mit Polymermultischichten |
DE10010264A1 (de) * | 2000-03-02 | 2001-09-13 | Novosom Gmbh | Stabilisierte Liposomen und Hüllstrukturen |
WO2001078687A1 (fr) * | 2000-04-18 | 2001-10-25 | Peptron Inc. | Composition pharmaceutique injectable a liberation durable et procedes de preparation de celle-ci |
EP1292385A1 (fr) * | 2000-04-28 | 2003-03-19 | Rainer Pommersheim | Procede et installation pour produire des microcapsules membranaires |
FR2809309B1 (fr) * | 2000-05-23 | 2004-06-11 | Mainelab | Microspheres a liberation prolongee pour administration injectable |
US6998393B2 (en) * | 2000-06-23 | 2006-02-14 | Biopharm Solutions, Inc. | Aquespheres, their preparation and uses thereof |
KR100392501B1 (ko) * | 2000-06-28 | 2003-07-22 | 동국제약 주식회사 | 다중 에멀젼법에 의한 서방출성 미립구의 제조방법 |
DE10031132A1 (de) * | 2000-06-30 | 2002-01-17 | Henkel Kgaa | Verfahren zur Herstellung aktivstoffhaltiger Kapseln mit ultradünner Wandschicht |
US20040013738A1 (en) * | 2000-08-02 | 2004-01-22 | Andreas Voigt | Encapsulation of liquid template particles |
DE60110809T2 (de) * | 2000-08-28 | 2005-10-06 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Mehrschichtige Polyelektrolytkapseln mit kontrollierter und verzögerter Freisetzung |
US6756062B2 (en) * | 2000-11-03 | 2004-06-29 | Board Of Regents University Of Texas System | Preparation of drug particles using evaporation precipitation into aqueous solutions |
JP2004517699A (ja) * | 2001-01-30 | 2004-06-17 | ボード オブ リージェンツ ユニバーシティ オブ テキサス システム | 液体中への噴霧凍結によるナノ粒子およびミクロ粒子の製造方法 |
US6896905B2 (en) * | 2001-02-15 | 2005-05-24 | Rohm And Haas Company | Porous particles, their aqueous dispersions, and method of preparation |
FR2824754B1 (fr) * | 2001-05-15 | 2004-05-28 | Separex Sa | Procede d'obtention de particules solides a partir d'au moins un produit hydrosoluble |
US6878693B2 (en) * | 2001-09-28 | 2005-04-12 | Solubest Ltd. | Hydrophilic complexes of lipophilic materials and an apparatus and method for their production |
EP1443912B1 (fr) * | 2001-10-12 | 2007-08-29 | Elan Pharma International Limited | Compositions combinant des caracteristiques de liberation immediate et de liberation prolongee |
US7112361B2 (en) * | 2001-10-25 | 2006-09-26 | Massachusetts Institute Of Technology | Methods of making decomposable thin films of polyelectrolytes and uses thereof |
US20040014698A1 (en) * | 2002-07-18 | 2004-01-22 | Gonzalo Hortelano | Oral administration of therapeutic agent coupled to transporting agent |
US6896926B2 (en) * | 2002-09-11 | 2005-05-24 | Novartis Ag | Method for applying an LbL coating onto a medical device |
DE10244503A1 (de) * | 2002-09-25 | 2004-04-08 | Capsulution Nanoscience Ag | Methode zur Herstellung und Stabilisierung von Mikro- und Nanosuspensionen mit Amphiphilen und Polyelektrolyten |
US20050142205A1 (en) * | 2003-07-18 | 2005-06-30 | Julia Rashba-Step | Methods for encapsulating small spherical particles prepared by controlled phase separation |
KR101137785B1 (ko) * | 2003-07-18 | 2012-04-25 | 백스터 인터내셔널 인코포레이티드 | 제어된 상 분리에 의해 제조된 작은 구형 입자의 제조방법, 이용 방법 및 조성물 |
AU2004258971A1 (en) * | 2003-07-22 | 2005-02-03 | Baxter Healthcare S.A. | Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof |
MXPA06012992A (es) * | 2004-05-12 | 2007-02-12 | Baxter Int | Microesferas que comprenden proteina y que muestran inyectabilidad en altas concentraciones de este agente. |
PT1765294E (pt) * | 2004-05-12 | 2008-12-30 | Baxter Healthcare Sa | Microesferas de ácido nucleico, sua produção e entrega |
CA2566199C (fr) * | 2004-05-12 | 2013-10-22 | Baxter International Inc. | Administration de microspheres d'oligonucleotides antisens pour induire une tolerance de cellules dendritiques pour le traitement du diabete de type 1 insulino-dependant |
-
2006
- 2006-04-27 CN CN2006800148125A patent/CN101188996B/zh not_active Expired - Fee Related
- 2006-04-27 WO PCT/US2006/015918 patent/WO2006116546A1/fr active Application Filing
- 2006-04-27 EP EP06751564A patent/EP1885335A1/fr not_active Withdrawn
- 2006-04-27 JP JP2008509099A patent/JP2008539259A/ja active Pending
- 2006-04-27 US US11/380,556 patent/US20060260777A1/en not_active Abandoned
- 2006-04-27 MX MX2007013356A patent/MX2007013356A/es active IP Right Grant
- 2006-04-27 CA CA002604225A patent/CA2604225A1/fr not_active Abandoned
- 2006-04-27 AU AU2006241145A patent/AU2006241145B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JP2008539259A (ja) | 2008-11-13 |
US20060260777A1 (en) | 2006-11-23 |
EP1885335A1 (fr) | 2008-02-13 |
WO2006116546A1 (fr) | 2006-11-02 |
CN101188996A (zh) | 2008-05-28 |
AU2006241145A1 (en) | 2006-11-02 |
MX2007013356A (es) | 2008-03-26 |
AU2006241145B2 (en) | 2011-04-28 |
CN101188996B (zh) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2006241145B2 (en) | Surface-modified microparticles and methods of forming and using the same | |
US20100009007A1 (en) | Non-covalent modification of microparticles and process of preparing same | |
US20080248122A1 (en) | Microencapsules Containing Surface-Modified Microparticles And Methods Of Forming And Using The Same | |
KR100789008B1 (ko) | 신규 약물 제제 | |
US20070281031A1 (en) | Microparticles and methods for production thereof | |
JP2024028820A (ja) | タンパク質治療薬をカプセル製剤化および徐放性製剤化を可能にするポリマーナノ粒子組成物 | |
García | Nano-and microparticles as drug carriers | |
CN109568601B (zh) | 一种蛋白多肽类药物双重微球及其制备方法和胰岛素双重微球 | |
AU2018287142B2 (en) | Albumin nanoparticles for the treatment of cancer and ocular diseases | |
KR101180181B1 (ko) | 나노 입자 및 그의 제조 방법 | |
CN101522177A (zh) | 包含表面改性微粒的微囊及其制备和使用方法 | |
EP4169509A1 (fr) | Particule contenant des nanoparticules lipidiques et procédé pour leur production | |
ES2654610T3 (es) | Métodos de procesamiento de composiciones que contienen micropartículas | |
Li et al. | Microparticles | |
Mahalekshmi et al. | Recent advancement of nanosponges in pharmaceutical formulation for drug delivery systems | |
RU2797114C2 (ru) | Наночастица и фармацевтическая композиция для лечения глазных заболеваний или рака | |
Silva et al. | Novel chitosan-based strategies for insulin nanoencapsulation | |
Nobre | Development and optimization of Supercritical CO2-Assisted Spray Drying process towards liposomal dry powders formulations | |
Iqbal | Preparation of submicron particles for theranostic applications: imaging and therapy | |
Ganesan et al. | Formulation and in vitro evaluation cefixime lipospheres | |
Samad et al. | 20 Microsphere | |
Chagar | Development of injectable pH-degradable polymeric particles containing thrombin for minimally invasive delivery of fibrin glue to the heart post-myocardial infraction | |
Pujari et al. | Emerging Intelligent Biological Dimension of Nanotechnology in Drug Delivery with Marked Emphasis on Antidiabetic Drugs | |
FTIR | Subject Index Volumes 307–325 (2006) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |
Effective date: 20150608 |